The global Steroids Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Corticosteroids, Anabolic-Androgenic Steroids), By Route of Administration (Topical, Inhalation, Injection, Oral), By Distribution Channel (Hospital, Online Retail, Offline Pharmacy, Others).
The steroids market is projected to grow steadily through 2025, driven by factors such as increasing use in medical treatments and rising consumer interest in athletic performance enhancement. Medical steroids, including corticosteroids and anabolic steroids, are prescribed for a variety of conditions such as autoimmune disorders, inflammation, and hormone deficiencies. In particular, corticosteroids are widely used in the treatment of diseases like asthma, arthritis, and allergies. Anabolic steroids are also used in specific medical conditions, such as muscle-wasting diseases and delayed puberty. However, the misuse of anabolic steroids for performance enhancement and bodybuilding purposes remains a controversial aspect of the market. The illegal use of anabolic steroids, combined with rising awareness of the potential health risks associated with their use, is prompting stricter regulations in many countries. The global market is also influenced by advancements in synthetic steroid production and ongoing research into new therapeutic uses for both anabolic and corticosteroids. The market is largely dominated by North America and Europe, but Asia-Pacific is expected to see strong growth due to increasing healthcare access and rising awareness of steroid-based treatments.
The market report analyses the leading companies in the industry including AbbVie Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi S.A, and others.
The steroids market is witnessing an increase in demand for performance-enhancing steroids, particularly in the sports and fitness sectors. Bodybuilders, athletes, and fitness enthusiasts continue to seek out anabolic steroids to help build muscle mass, improve endurance, and accelerate recovery. However, there is an increasing focus on the legality and ethical implications surrounding steroid use, leading to the growth of alternative, legal performance-enhancing supplements. This trend has sparked a rise in research and development aimed at creating steroid alternatives that provide similar benefits without the associated health risks and legal concerns.
A significant driver of the steroids market is the expanding use of steroids in the treatment of chronic conditions such as arthritis, asthma, and hormone deficiencies. Corticosteroids are commonly used to reduce inflammation, while anabolic steroids are increasingly prescribed in hormone replacement therapy (HRT) for individuals with low testosterone levels. As the global population ages and the prevalence of chronic diseases rises, the demand for steroids for therapeutic purposes is expected to grow. Additionally, as more doctors prescribe steroids for legitimate medical conditions, the overall market is poised for continued expansion.
An emerging opportunity in the steroids market lies in the development of natural and herbal steroid alternatives that promise similar benefits without the adverse side effects associated with synthetic steroids. These alternatives, derived from plant-based sources, are gaining popularity among health-conscious consumers who are wary of the long-term health risks posed by synthetic steroids. As demand for safer, more natural alternatives continues to rise, companies can capitalize on this trend by developing and marketing products that provide muscle-building and performance-enhancing benefits through organic and herbal ingredients.
The Anabolic-Androgenic Steroids (AAS) segment is expected to be the largest revenue contributor in the Steroids market by 2025. AAS are widely used in various applications, including sports and bodybuilding, to enhance muscle growth, improve performance, and support recovery. Despite concerns over misuse and regulatory restrictions, the demand for anabolic steroids remains strong due to their popularity among athletes and fitness enthusiasts seeking to boost strength and endurance. Furthermore, the medical application of AAS in treating muscle wasting diseases and hormone deficiencies continues to support the segment's growth. As a result, the anabolic-androgenic steroids segment is projected to maintain its dominance, driven by both recreational and therapeutic uses.
The oral administration segment in the steroids market is expected to grow at the fastest rate over the forecast period through 2034. This growth is driven by the increasing preference for oral steroid formulations due to their convenience and ease of use. Oral steroids are widely used for treating a variety of conditions, including inflammation, asthma, and autoimmune diseases, making them an essential part of many therapeutic regimens. The market is witnessing a growing demand for oral steroid drugs that offer rapid onset of action and patient compliance, especially in outpatient settings. Additionally, as advancements in pharmaceutical formulations enhance the bioavailability and safety profiles of oral steroids, this segment is anticipated to dominate the market's growth in the coming years.
In China, the steroids market is expanding as the country’s increasing focus on health, fitness, and athletic performance fuels demand for anabolic steroids. With China’s rising middle class, there is a growing interest in bodybuilding and fitness activities, which has resulted in higher consumption of steroids for performance enhancement. Additionally, the medical use of steroids, especially corticosteroids for the treatment of inflammatory diseases, is on the rise, contributing to market growth. The country’s vast population and growing healthcare infrastructure also play a significant role in boosting sales. However, stricter regulations and growing awareness about the potential risks associated with steroid use are pushing the market towards more regulated and safer steroid products. The increasing popularity of online pharmacies and platforms in China is also making steroid products more accessible to a broader audience.
In India, the steroids market is driven by the rising popularity of bodybuilding and fitness culture, particularly among the younger population. As more Indian consumers seek quick results in physical performance and aesthetic enhancement, demand for anabolic steroids has surged. The country's expanding middle class and increasing disposable incomes are enabling more people to afford fitness memberships and supplements, including steroids. Additionally, India’s growing number of athletes and fitness enthusiasts in competitive sports is contributing to market growth. However, the Indian government’s focus on regulating steroid use due to health concerns is prompting a shift towards safer, prescription-based steroid use, especially for medical conditions such as autoimmune diseases and asthma. The prevalence of online platforms and e-commerce is also making steroids more accessible to a wider segment of the population.
The United States represents a significant portion of the global steroids market, driven by a strong fitness culture, a high number of professional athletes, and the growing demand for cosmetic surgery. Anabolic steroids are widely used by bodybuilders and athletes to enhance performance and physique, contributing to the market's growth. The increasing acceptance of steroids in the healthcare sector, particularly for medical conditions like arthritis, asthma, and other autoimmune disorders, is also propelling market demand. Additionally, with the rising trend of personal health optimization, many individuals are turning to steroids for muscle recovery and anti-aging benefits. However, the U.S. government’s regulations and the growing awareness of the side effects associated with improper steroid use are encouraging consumers to choose safer, more regulated products, including those that focus on natural alternatives.
In Germany, the steroids market is influenced by the country’s robust sports culture, increasing healthcare expenditure, and growing interest in fitness and bodybuilding. As more Germans engage in fitness activities and competitive sports, there is a rising demand for steroids to boost performance and muscle mass. The use of corticosteroids in Germany for the treatment of inflammatory diseases such as arthritis, asthma, and autoimmune disorders also drives the medical segment of the market. The German government’s stringent regulations on steroid use and distribution are pushing the market towards safer, regulated products. Furthermore, the growing trend of preventive healthcare and fitness in urban areas, coupled with increasing online sales of supplements and medications, is further stimulating the market for steroids in the country.
In France, the steroids market is experiencing gradual growth, primarily driven by the country’s strong interest in fitness and sports. As the popularity of bodybuilding and athletic performance-enhancing products continues to rise, there is a growing demand for steroids, particularly in the younger demographic. Steroids are also used in the medical field to treat conditions such as inflammatory diseases and hormonal imbalances. However, France's regulatory framework around steroid use is relatively strict, which has led to a preference for legal, medical-grade steroids. The country’s increasing awareness of health and wellness, along with a growing demand for performance-enhancing products, is leading to a more controlled but expanding market. Additionally, online health platforms and e-commerce are making steroids more accessible to fitness enthusiasts and those seeking medical treatments.
The Middle East has seen a rise in the steroids market, particularly in countries like the UAE, Saudi Arabia, and Qatar, where bodybuilding and fitness are becoming increasingly popular. The affluent populations in these regions are driving demand for both anabolic steroids for performance enhancement and corticosteroids for medical uses. The growing interest in fitness, combined with a high number of gym memberships and health clubs, is propelling the market forward. In the medical sector, steroids are widely used to treat conditions such as asthma, autoimmune disorders, and skin diseases. However, the Middle East's strict regulations on steroid use are encouraging consumers to seek out safer, legally approved products. Additionally, the rise in online shopping and e-commerce platforms in the region is making it easier for individuals to access steroids for both medical and non-medical purposes.
|
Parameter |
Details |
|
Market Size (2025) |
$8.4 Billion |
|
Market Size (2034) |
$14 Billion |
|
Market Growth Rate |
5.8% |
|
Segments |
By Type (Corticosteroids, Anabolic-Androgenic Steroids), By Route of Administration (Topical, Inhalation, Injection, Oral), By Distribution Channel (Hospital, Online Retail, Offline Pharmacy, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
AbbVie Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi S.A |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Type
Corticosteroids
Anabolic-Androgenic Steroids
By Route of Administration
Topical
Inhalation
Injection
Oral
By Distribution Channel
Hospital
Online Retail
Offline Pharmacy
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AbbVie Inc
AstraZeneca
Bayer AG
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Novartis International AG
Pfizer Inc
Sanofi S.A
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Steroids Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Steroids Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Steroids Market Size by Segments, 2018- 2024
Key Statistics, 2024
Steroids Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Steroids Types, 2018- 2024
Steroids Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Steroids Applications, 2018- 2024
8. Steroids Market Size Outlook by Segments, 2024- 2034
By Type
Corticosteroids
Anabolic-Androgenic Steroids
By Route of Administration
Topical
Inhalation
Injection
Oral
By Distribution Channel
Hospital
Online Retail
Offline Pharmacy
Others
9. Steroids Market Size Outlook by Region
North America
Key Market Dynamics
North America Steroids Market Size Outlook by Type, USD Million, 2021-2034
North America Steroids Market Size Outlook by Application, USD Million, 2021-2034
North America Steroids Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Steroids Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Steroids Market Size Outlook by Type, USD Million, 2021-2034
Europe Steroids Market Size Outlook by Application, USD Million, 2021-2034
Europe Steroids Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Steroids Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Steroids Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Steroids Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Steroids Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Steroids Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Steroids Market Size Outlook by Type, USD Million, 2021-2034
South America Steroids Market Size Outlook by Application, USD Million, 2021-2034
South America Steroids Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Steroids Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Steroids Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Steroids Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Steroids Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Steroids Market Size Outlook by Country, USD Million, 2021-2034
10. United States Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Steroids Market Size Outlook by Type, 2021- 2034
United States Steroids Market Size Outlook by Application, 2021- 2034
United States Steroids Market Size Outlook by End-User, 2021- 2034
11. Canada Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Steroids Market Size Outlook by Type, 2021- 2034
Canada Steroids Market Size Outlook by Application, 2021- 2034
Canada Steroids Market Size Outlook by End-User, 2021- 2034
12. Mexico Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Steroids Market Size Outlook by Type, 2021- 2034
Mexico Steroids Market Size Outlook by Application, 2021- 2034
Mexico Steroids Market Size Outlook by End-User, 2021- 2034
13. Germany Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Steroids Market Size Outlook by Type, 2021- 2034
Germany Steroids Market Size Outlook by Application, 2021- 2034
Germany Steroids Market Size Outlook by End-User, 2021- 2034
14. France Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
France Steroids Market Size Outlook by Type, 2021- 2034
France Steroids Market Size Outlook by Application, 2021- 2034
France Steroids Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Steroids Market Size Outlook by Type, 2021- 2034
United Kingdom Steroids Market Size Outlook by Application, 2021- 2034
United Kingdom Steroids Market Size Outlook by End-User, 2021- 2034
16. Spain Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Steroids Market Size Outlook by Type, 2021- 2034
Spain Steroids Market Size Outlook by Application, 2021- 2034
Spain Steroids Market Size Outlook by End-User, 2021- 2034
17. Italy Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Steroids Market Size Outlook by Type, 2021- 2034
Italy Steroids Market Size Outlook by Application, 2021- 2034
Italy Steroids Market Size Outlook by End-User, 2021- 2034
18. Benelux Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Steroids Market Size Outlook by Type, 2021- 2034
Benelux Steroids Market Size Outlook by Application, 2021- 2034
Benelux Steroids Market Size Outlook by End-User, 2021- 2034
19. Nordic Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Steroids Market Size Outlook by Type, 2021- 2034
Nordic Steroids Market Size Outlook by Application, 2021- 2034
Nordic Steroids Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Steroids Market Size Outlook by Type, 2021- 2034
Rest of Europe Steroids Market Size Outlook by Application, 2021- 2034
Rest of Europe Steroids Market Size Outlook by End-User, 2021- 2034
21. China Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
China Steroids Market Size Outlook by Type, 2021- 2034
China Steroids Market Size Outlook by Application, 2021- 2034
China Steroids Market Size Outlook by End-User, 2021- 2034
22. India Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
India Steroids Market Size Outlook by Type, 2021- 2034
India Steroids Market Size Outlook by Application, 2021- 2034
India Steroids Market Size Outlook by End-User, 2021- 2034
23. Japan Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Steroids Market Size Outlook by Type, 2021- 2034
Japan Steroids Market Size Outlook by Application, 2021- 2034
Japan Steroids Market Size Outlook by End-User, 2021- 2034
24. South Korea Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Steroids Market Size Outlook by Type, 2021- 2034
South Korea Steroids Market Size Outlook by Application, 2021- 2034
South Korea Steroids Market Size Outlook by End-User, 2021- 2034
25. Australia Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Steroids Market Size Outlook by Type, 2021- 2034
Australia Steroids Market Size Outlook by Application, 2021- 2034
Australia Steroids Market Size Outlook by End-User, 2021- 2034
26. South East Asia Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Steroids Market Size Outlook by Type, 2021- 2034
South East Asia Steroids Market Size Outlook by Application, 2021- 2034
South East Asia Steroids Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Steroids Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Steroids Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Steroids Market Size Outlook by End-User, 2021- 2034
28. Brazil Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Steroids Market Size Outlook by Type, 2021- 2034
Brazil Steroids Market Size Outlook by Application, 2021- 2034
Brazil Steroids Market Size Outlook by End-User, 2021- 2034
29. Argentina Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Steroids Market Size Outlook by Type, 2021- 2034
Argentina Steroids Market Size Outlook by Application, 2021- 2034
Argentina Steroids Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Steroids Market Size Outlook by Type, 2021- 2034
Rest of South America Steroids Market Size Outlook by Application, 2021- 2034
Rest of South America Steroids Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Steroids Market Size Outlook by Type, 2021- 2034
United Arab Emirates Steroids Market Size Outlook by Application, 2021- 2034
United Arab Emirates Steroids Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Steroids Market Size Outlook by Type, 2021- 2034
Saudi Arabia Steroids Market Size Outlook by Application, 2021- 2034
Saudi Arabia Steroids Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Steroids Market Size Outlook by Type, 2021- 2034
Rest of Middle East Steroids Market Size Outlook by Application, 2021- 2034
Rest of Middle East Steroids Market Size Outlook by End-User, 2021- 2034
34. South Africa Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Steroids Market Size Outlook by Type, 2021- 2034
South Africa Steroids Market Size Outlook by Application, 2021- 2034
South Africa Steroids Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Steroids Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Steroids Market Size Outlook by Type, 2021- 2034
Rest of Africa Steroids Market Size Outlook by Application, 2021- 2034
Rest of Africa Steroids Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
AbbVie Inc
AstraZeneca
Bayer AG
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Novartis International AG
Pfizer Inc
Sanofi S.A
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Type
Corticosteroids
Anabolic-Androgenic Steroids
By Route of Administration
Topical
Inhalation
Injection
Oral
By Distribution Channel
Hospital
Online Retail
Offline Pharmacy
Others
The Global Steroids Market Size is estimated at $8.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 5.8% to reach $14 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AbbVie Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi S.A
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume